Chronic lymphocytic leukemia registry study for adults
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study collects information from people with chronic lymphocytic leukemia (CLL) to better understand the disease over time. If you join, you would share your medical and health details and give consent to be included in the registry.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic lymphocytic leukemia (CLL)
- You are 18 years old or older
- You are able and willing to sign written study consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information over time from people with CLL to better understand the disease and its treatment. It does not test any new drugs or procedures.
This study looks at what it’s like to live with chronic lymphocytic leukemia while participating in a clinical research protocol. It may help researchers understand patient experiences and improve how future trials are run.
This study aims to learn more about chronic lymphocytic leukemia (CLL) and closely related conditions. It may help researchers better understand who gets CLL and how it behaves over time, which can improve future care.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study is a registry that collects information about people with certain types of leukemia. It may help researchers understand the disease course and how patients are treated, including people who are newly diagnosed, currently treated, referred for transplant, or have relapsed.
This study collects information from people diagnosed with chronic lymphatic leukemia. It may help doctors better understand the disease, track patient needs, and improve future care.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.